BENITEC BIOPHARMA

In News

Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target - TipRanks

TipRanks - Mar 02, 2026

Benitec Biopharma Announces Acceptance of Late- Breaking - GlobeNewswire

GlobeNewswire - Feb 23, 2026

We're Not Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn - 富途牛牛

富途牛牛 - Mar 05, 2026

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Yahoo Finance

Yahoo Finance - Feb 14, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

MarketBeat - Feb 28, 2026

Durable BB-301 responses in muscular dystrophy to be detailed at MDA 2026 - Stock Titan

Stock Titan - Feb 23, 2026

BENITEC BIOPHARMA ($BNTC) Releases Q2 2026 Earnings - Quiver Quantitative

Quiver Quantitative - Feb 12, 2026

Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data - Investing.com

Investing.com - Jan 12, 2026

Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to long-term losses - Sahm

Sahm - Feb 14, 2026

Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update - GlobeNewswire

GlobeNewswire - Feb 12, 2026

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301 - Yahoo Finance

Yahoo Finance - Nov 03, 2025

Benitec Biopharma (NASDAQ:BNTC) Shares Cross Below 50-Day Moving Average - Here's Why - MarketBeat

MarketBeat - Feb 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment